171 related articles for article (PubMed ID: 19729021)
1. Immunomodulation and matrix metalloproteinases in viral myocarditis.
Westermann D; Savvatis K; Schultheiss HP; Tschöpe C
J Mol Cell Cardiol; 2010 Mar; 48(3):468-73. PubMed ID: 19729021
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases in the pathogenesis of viral heart disease.
Marchant D; McManus BM
Trends Cardiovasc Med; 2009 Jan; 19(1):21-6. PubMed ID: 19467450
[TBL] [Abstract][Full Text] [Related]
3. Myocardial proteases and matrix remodeling in inflammatory heart disease.
Rutschow S; Li J; Schultheiss HP; Pauschinger M
Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902
[TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of extracellular matrix remodeling in dilated cardiomyopathy].
Pauschinger M; Chandrasekharan K; Li J; Schwimmbeck PL; Noutsias M; Schultheiss HP
Herz; 2002 Nov; 27(7):677-82. PubMed ID: 12439639
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function.
Smith MF; McIntush EW; Ricke WA; Kojima FN; Smith GW
J Reprod Fertil Suppl; 1999; 54():367-81. PubMed ID: 10692869
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
8. Role of matrix metalloproteinases in melanoma cell invasion.
Hofmann UB; Houben R; Bröcker EB; Becker JC
Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317
[TBL] [Abstract][Full Text] [Related]
9. Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system.
Pauschinger M; Chandrasekharan K; Schultheiss HP
Heart Fail Rev; 2004 Jan; 9(1):21-31. PubMed ID: 14739765
[TBL] [Abstract][Full Text] [Related]
10. Extracellular matrix remodelling: the role of matrix metalloproteinases.
Stamenkovic I
J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
[TBL] [Abstract][Full Text] [Related]
11. Interactions between the extracellular matrix and inflammation during viral myocarditis.
Papageorgiou AP; Heymans S
Immunobiology; 2012 May; 217(5):503-10. PubMed ID: 21907443
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
13. [Matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathogenesis of rheumatoid arthritis].
Fiedorczyk M; Klimiuk PA; Sierakowski S; Kita K
Pol Merkur Lekarski; 2006 Feb; 20(116):228-31. PubMed ID: 16708647
[TBL] [Abstract][Full Text] [Related]
14. Myocarditis and dilated cardiomyopathy: possible connections and treatments.
Castellano G; Affuso F; Di Conza P; Fazio S
J Cardiovasc Med (Hagerstown); 2008 Jul; 9(7):666-71. PubMed ID: 18545064
[TBL] [Abstract][Full Text] [Related]
15. Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.
Jodele S; Blavier L; Yoon JM; DeClerck YA
Cancer Metastasis Rev; 2006 Mar; 25(1):35-43. PubMed ID: 16680570
[TBL] [Abstract][Full Text] [Related]
16. Targeting matrix metalloproteinase activity and expression for the treatment of viral myocarditis.
Hendry RG; Bilawchuk LM; Marchant DJ
J Cardiovasc Transl Res; 2014 Mar; 7(2):212-25. PubMed ID: 24381086
[TBL] [Abstract][Full Text] [Related]
17. Endothelial sprouting and angiogenesis: matrix metalloproteinases in the lead.
van Hinsbergh VW; Koolwijk P
Cardiovasc Res; 2008 May; 78(2):203-12. PubMed ID: 18079100
[TBL] [Abstract][Full Text] [Related]
18. [The role of matrix metalloproteinases and their tissue inhibitors in angiogenesis].
Bogaczewicz J; Dudek W; Zubilewicz T; Wroński J; Przywara S; Chodorowska G; Krasowska D
Pol Merkur Lekarski; 2006 Jul; 21(121):80-5. PubMed ID: 17007300
[TBL] [Abstract][Full Text] [Related]
19. Role of matrix metalloproteinases in the inflammatory process of respiratory diseases.
Lagente V; Boichot E
J Mol Cell Cardiol; 2010 Mar; 48(3):440-4. PubMed ID: 19818795
[TBL] [Abstract][Full Text] [Related]
20. Pathways of matrix metalloproteinase induction in heart failure: bioactive molecules and transcriptional regulation.
Deschamps AM; Spinale FG
Cardiovasc Res; 2006 Feb; 69(3):666-76. PubMed ID: 16426590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
